The objectives of this study were firstly to determine HIV (human immunodeficiency virus) prevalence in the rural Free State, secondly to classify the stages of HIV by utilising CD 4 (cluster of differentiation 4) counts, and thirdly to measure differences in haematological abnormalities between HIV-uninfected and HIV-infected participants.
Introduction
The five countries with the highest HIV (human immunodeficiency virus) prevalence rates in the world are situated in Southern Africa and South Africa. 1 The Nelson Mandela Trust and Human Science Research Council (HSRC) study of HIV and AIDS (Nelson Mandela Human Sciences Research Council 2002) was the first to describe the prevalence of HIV infection in the total South African population and to provide a detailed picture of the distribution and determinants of this devastating pandemic.
In a recent national community-based survey 3 which included 7249 households and 13 518 individuals, the prevalence of HIV in the general population was 11.4%, with 12.8% prevalence in female participants and 9.5% prevalence in male participants. In formal urban areas, the prevalence in the Black population was 12.9%, 6.2% in the White population, 6.1% in the Coloured population, and 1.6% in the Indian population. Informal settlements in urban areas had a prevalence of 21.6%. The prevalence of HIV in urban formal and informal areas is higher (11.9% and 21.6%, respectively) than in rural formal and informal areas (7.8% and 8.8%, respectively). The peak prevalence occurred in women between ages 20-29 years (24.1%) and in men between 30-39 years (21.3%). The prevalence of HIV infection in the Free State province was reported to be 14.9%. 3 In 2006, the prevalence of HIV in antenatal clinic attendees in South Africa was 29.1%, with the peak prevalence (38.7%) in the 25-29 years age group. In the Free State, 31.1% of attendees were HIV-infected, whilst KwaZulu-Natal had the highest prevalence at 39.1%. 4 Staging is used to classify the disease into groups with different prognoses. Clinicians may use staging as a guide to treatment and medical management of patients. The proposed staging system for HIV infection constructed by the Centres for Disease Control and Prevention (CDC) 5 has gained wide acceptance. The CDC uses CD 4 
Ethical considerations
Approval to conduct the investigation was obtained from the Ethics Committee of the Faculty of Health Science at the University of the Free State (ETOVS nr: 21/7), the Department of Health and local municipalities. Before the onset of the study, all households were visited by trained fieldworkers and informed written consent to participate was obtained in the language of choice. Participation was voluntary and participants could withdraw at any time.
Methods
The rural baseline study was performed over a 10-day period More women than men took part in the study, most probably because more men are employed as labourers in the vicinity. As a result of the aforementioned reasons, we acknowledge that the study group is not in essence representative of the general population.
All information was treated as strictly confidential. Preintervention and postintervention counselling was given by trained medical practitioners. After completion of the rural baseline study, the participants were referred to the relevant local or provincial medical services for management and follow-up.
All participants were screened for their HIV status, using two fourth-generation serum assays. 
Results
Participants (n = 552) aged between 25 and 64 years were included in the study, of which 28.1% were male (mean age 47.3 years) and 71.9% were female (mean age 46.0 years).
The HIV status of all participants was unknown. The prevalence of HIV infection in this survey was 17.1% (16.5% in female participants and 18.2% in male participants). The peak prevalence of HIV in female participants was observed in the age group 31-40 years (41.3%), and in male participants in the age group 41-50 years (37.9%). Springfontein had the highest prevalence of HIV infection (18.2%) and Trompsburg the lowest (15.3%).
The distribution of CD 4 counts, which were performed only on HIV-infected participants, showed that 30.4%, 42.4% and 27.2% of participants had CD 4 Haematological results showed that HIV-infected participants had significantly reduced haemoglobin-values (for male participants p < 0.01, and for female participants p < 0.0001), neutrophil (p < 0.01) and lymphocyte values, in comparison to HIV-uninfected participants. No significant difference was observed between mean corpuscular volume and platelet counts of HIV-infected and HIV-uninfected participants (Table 1) .
Discussion
The Springfontein, Trompsburg, Philippolis area represents rural Southern Free State with mixed formal and informal settlements. The prevalence of HIV infection (17.1%) was slightly higher than previously reported (14.9%), 3 which included urban settlements of the Free State and was therefore not comparable to our data. In South Africa, the prevalence of HIV was 7.8% in rural formal settlements and 8.8% in rural informal settlements, 3 which was much lower than our observations. Our study group is probably not representative of the general population because of reasons previously outlined, and this may explain the higher, but not statistically significant (p ≤ 0.48) prevalence of HIV infection in Springfontein (18.2%) compared to Trompsburg (15.3%). It could also explain the prevalence differences between our results and published community-based surveys. 3 It has been reported that HIV prevalence peaks in women aged 20-29 years (24.1%) and in men at the age of 30-39 years (21.3%). 3 In our study, however, it was observed that HIV prevalence peaked later (between 31-40 years in women and 41-50 years in men). The observation that peak prevalence of HIV infection in women occurs at a younger age than in men, may reflect the fact that men tend to have sexual partners younger than themselves. 7 The peak prevalence of HIV infection in our study occurred later than previously described, 3 probably because our data, which included only rural participants, were compared to observations that represented participants from all over South Africa, including urban participants. immune system, which weakens with progression of HIV infection until levels lower than 200 cells/mm 3 are reached.
5
Low CD 4 counts are associated with a compromised immune system, serious infections and general health problems. In our study, the CD 4 count was less than 200 cells/mm 3 in 27.2% of HIV-infected participants, of whom none had received antiretroviral treatment. The peak prevalence of HIV infection in the age group 31-40 years supported the significantly low mean CD 4 count (276 cells/mm 3 ) in the age group 41-50 years ( Figure 1 ). This finding suggests that it takes approximately 10 years from the onset of the infection with the virus until the progression into acquired immune deficiency syndrome (AIDS). It was previously observed that the median survival varied from 12.5 years for those aged 15-24 years at seroconversion to 7.9 years for those aged 45-54 years at seroconversion. The corresponding values for the development of AIDS were 11.0 years and 7.7 years. 9 Haemoglobin was significantly reduced in HIV-infected male participants (p < 0.01) and female participants (p < 0.000 1) compared to uninfected participants (Table  1) . Anaemia could have contributed to symptoms such as fatigue and breathlessness. It is more common amongst people with HIV infection and might be caused by HIV itself, opportunistic infections or the treatment. 6 Significantly reduced haemoglobin values found in HIV-uninfected male participants (p < 0.01) and female participants (p < 0.0001) were probably indicative of a generally ill study population.
The number as well as the different types of white blood cells (Table 1) were measured. In contrast to HIV-uninfected participants, significantly reduced white blood cell counts (p < 0.001) and neutrophil counts (p < 0.005), might enhance the risk of bacterial and fungal infections in HIV-infected participants. 6 The significantly reduced lymphocyte counts (p < 0.005) observed in our study are associated with HIV-related infection and killing of CD 4 T-cells. 8 It is recommended that the rural data obtained in this study be compared to that of an urban area to explain differences between our data and that of other studies. Data will be obtained from urban areas as well, as part of the continuing AHA FS study currently in progress in the Free State province.
Conclusion
Low CD 4 counts were associated with a compromised immune system, serious infections and general health problems. In our study, the CD 4 count was less than 200 cells/mm 3 in 27.2% of HIV-infected participants, of whom none had received antiretroviral treatment. Anaemia, also found in HIV-uninfected male participants and female participants, are probably indicative of a generally ill study population.
